This brand name is authorized in Ecuador
The drug ACROMIZOL contains one active pharmaceutical ingredient (API):
UNII VW4H1CYW1K - MICONAZOLE NITRATE
Miconazole possesses an antifungal activity against the common dermatophytes and yeasts as well as an antibacterial activity against certain gram-positive bacilli and cocci. Its activity is based on the inhibition of the ergosterol biosynthesis in fungi and the change in the composition of the lipid components in the membrane, resulting in fungal cell necrosis.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
|A Alimentary tract and metabolism → A01 Stomatological preparations → A01A Stomatological preparations → A01AB Antiinfectives and antiseptics for local oral treatment
|D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
This drug has been assigned below unique identifiers within the countries it is being marketed:
|Agencia Nacional de Regulación, Control y Vigilancia Sanitaria
|Identifier(s): 03474-MAN-03-05, 2626-MEN-0420, 3330-MEN-1021, 7.239-2-05-04
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.